Search CommunityWalk:


Panacea Pharmaceuticals, Inc.

209 Perry Parkway, Suite 13
Gaithersburg, MD, USA

Category: Diagnostic/Imaging; Research Services & Supplies

Used in the following map:

Maryland Biotech Industry Map

Panacea Pharmaceuticals, Inc. discovers, develops and commercializes therapeutic and diagnostic products for cancer and diseases of the central nervous system. The company was founded in 1999 by Hossein A. Ghanbari. The company's division is Panacea Laboratories.

Panacea's core technologies exploit changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation. The company has active programs in cancer, stroke/ischemia, Alzheimer's disease, and Parkinson's disease. The company's products include: PAN-22, a fully human anit-HAAH monoclonal antibody for the treatment of hepatocellular carcinoma, PAN-622 - Toxin Conjugate for the treatment of carcinoma of the bile duct and PAN-811 for treatment of Ischemic Stroke.

Panacea has collaborations with National Institutes of Health, United States Department of Health and Human Services, National Institute on Aging, US Army, SRL, Inc., JSR Corporation, Massachusetts General Hospital, The Harvard University, etc.